Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03380351 · ClinicalTrials.gov registry record
Specifying Interventions From the Sickle Cell Disease Implementation Consortium (SCDIC)
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 17
- Enrollment target
NCT03380351 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 17 participants.
The verdict
NCT03380351 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
The goal of this study is to specify the interventions, implementation strategies and control conditions from the Sickle Cell Disease Implementation Consortium (SCDIC) using a mixed-methods approach to study site materials and conduct semi-structured qualitative interviews with site representatives (N=3 per site). We focused on the Emergency Department Working Group from the SCDIC working groups.
Interventions
- BEHAVIORAL SCDIC interventions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2019-08-26 |
| Est. Completion | 2024-03-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03380351
The ClinicalTrials.gov registry entry for NCT03380351 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SCDIC interventions is the first listed.
NCT03380351 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03380351 about?
NCT03380351 is a clinical study titled "Specifying Interventions From the Sickle Cell Disease Implementation Consortium (SCDIC)". The goal of this study is to specify the interventions, implementation strategies and control conditions from the Sickle Cell Disease Implementation Consortium (SCDIC) using a mixed-methods approach to study site materials and conduct semi-structured qualitative interviews with site representatives ...
What is the current status of trial NCT03380351?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2019-08-26. Estimated completion is 2024-03-30.
What interventions are being tested in trial NCT03380351?
The interventions under investigation include: SCDIC interventions (BEHAVIORAL).
Who is sponsoring clinical trial NCT03380351?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.